ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Atara Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.96−0.22 (-2.40%)
Close on Oct 19, 2026
- Market cap
- $134.70M
- P/E (TTM)
- 3.5
- Dividend yield
- –
SEC filings
40 of Atara Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | May 1, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 24, 2026 | Apr 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2025 | Jan 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2025 | Oct 7, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2025 | Jul 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 11, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Apr 4, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 31, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 7, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 7, 2025 | Mar 7, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2025 | Jan 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2025 | Jan 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 16, 2025 | Jan 16, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |